BBVA USA’s AbbVie ABBV Stock Holding History

BBVA USA’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.5M	Sell	41,683 -99	-0.2%	-$11.3K	0.26%	80
2021 Q2	$4.71M	Buy	+41,782	New	+$4.71M	0.26%	83

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBVA USA's ABBV Position: Q3 2021 in Review

BBVA USA reduced its AbbVie (ABBV) stake by 0.24% in Q3 2021, selling an estimated $11.3K and leaving 41,683 shares worth $4.5M. The position accounts for 0.26% of the portfolio, ranked #80.

BBVA USA first reported a position in ABBV in Q2 2021 and has held it in 2 quarters since. The position peaked at $4.71M in Q2 2021. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

BBVA USA held 41,683 shares of AbbVie worth $4.5M as of Q3 2021.
BBVA USA sold 99 AbbVie shares in Q3 2021, an estimated $11.3K.
AbbVie made up 0.26% of BBVA USA's portfolio in Q3 2021, its #80 holding.
BBVA USA first reported a position in AbbVie in Q2 2021 and has held it in 2 quarters since.
BBVA USA's AbbVie position peaked at $4.71M in Q2 2021.
2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.